The marker gpc1+ used in the study can effectively distinguish pancreatic cancer from the control group, providing a feasible and effective way to detect pancreatic cancer (Figure 8b).[117] With a shuttle flow mode of the microfluidic method, Chen et al. The gene discussed is GPC1; the disease is familial pancreatic carcinoma.